UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The demand for a COVID-19 vaccine in Ecuador

Vaccine, 2020-12, Vol.38 (51), p.8090-8098

2020

Volltextzugriff (PDF)

New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates

Vaccine, 2021-01, Vol.39 (2), p.197-201

2021

Volltextzugriff (PDF)

Intradermal fractional dose vaccination as a method to vaccinate individuals with suspected allergy to mRNA COVID-19 vaccines

Vaccine, 2024-11, Vol.42 (25), p.126093, Article 126093

2024

Volltextzugriff (PDF)

COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies

Vaccine, 2024-10, Vol.42 (24), p.126074, Article 126074

2024

Volltextzugriff (PDF)

Editorial: ML-driven vaccine against COVID-19: Developmental challenges and foresight

Vaccine, 2024-10, Vol.42 (23), p.126267, Article 126267

2024

Volltextzugriff (PDF)

Case-cohort design as an efficient approach to evaluating COVID-19 vaccine effectiveness, waning, heterologous immune effect and optimal dosing interval

Vaccine, 2024-11, Vol.42 (25), p.126134, Article 126134

2024

Volltextzugriff (PDF)

Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study

Vaccine, 2024-06, Vol.42 (16), p.3536-3546

2024

Volltextzugriff (PDF)

Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development

Vaccine, 2024-06, Vol.42 (17), p.3664-3673

2024

Volltextzugriff (PDF)

Insights from an observational translational research program during the COVID-19 pandemic: Four years of experience

Vaccine, 2024-10, Vol.42 (24), p.126306, Article 126306

2024

Volltextzugriff (PDF)

Leveraging a clinical emergency department dataset to estimate two-dose COVID-19 vaccine effectiveness and duration of protection in Canada

Vaccine, 2024-10, Vol.42 (23), p.126058, Article 126058

2024

Volltextzugriff (PDF)

Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial

Vaccine, 2024-11, Vol.42 (25), p.126117, Article 126117

2024

Volltextzugriff (PDF)

mRNA-based COVID-19 vaccination of lung transplant recipients with prior SARS-CoV-2 infection induces durable SARS-CoV-2-specific antibodies and T cells

Vaccine, 2024-10, Vol.42 (24), p.126250, Article 126250

2024

Volltextzugriff (PDF)

Longitudinal multiomic profiling and corticosteroid modulation of the immediate innate immune response to an adenovirus-vector vaccine

Vaccine, 2024-11, Vol.42 (25), p.126118, Article 126118

2024

Volltextzugriff (PDF)

Nonclinical safety assessment and immunogenicity of rVSVInd(GML)-mspSGtc vaccine for SARS-CoV-2 in rabbits

Vaccine, 2023-11, Vol.41 (46), p.6842-6851

2023

Volltextzugriff (PDF)

Mammalian cell expressed recombinant trimeric spike protein is a potent vaccine antigen and confers near-complete protection against SARS-CoV-2 infection in Hamster

Vaccine, 2024-08, Vol.42 (20), p.126099, Article 126099

2024

Volltextzugriff (PDF)

Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell lines

Vaccine, 2023-10, Vol.41 (44), p.6502-6513

2023

Volltextzugriff (PDF)

Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2-derived RBD antigen

Vaccine, 2024-05, Vol.42 (14), p.3355-3364

2024

Volltextzugriff (PDF)

Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group

Vaccine, 2021-01, Vol.39 (4), p.633-640

2021

Volltextzugriff (PDF)

Non-specific effects of the inactivated influenza vaccine. A test-negative study: The inactivated influenza vaccine and SARS-CoV-2 infections

Vaccine, 2024-05, Vol.42 (15), p.3455-3460

2024

Volltextzugriff (PDF)

Immunity of Canadians and risk of epidemics workshop – Conference report

Vaccine, 2023-11, Vol.41 (46), p.6775-6781

2023

Volltextzugriff (PDF)

Seroprevalence of B. pertussis infection and the changes of specific antibody levels in health care workers during the first two years of COVID-19 in Wuhu, China

Vaccine, 2024-10, Vol.42 (23), p.126239, Article 126239

2024

Volltextzugriff (PDF)

Importance of COVID-19 vaccine efficacy in older age groups

Vaccine, 2021-04, Vol.39 (15), p.2020-2023

2021

Volltextzugriff (PDF)

A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine

Vaccine, 2024-09, Vol.42 (22), p.126165, Article 126165

2024

Volltextzugriff (PDF)

Avidity assay to test functionality of anti-SARS-Cov-2 antibodies

Vaccine, 2021-03, Vol.39 (10), p.1473-1475

2021

Volltextzugriff (PDF)

1 – 25 von 907

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library

SpracheDeutsch

Zeitschrift / SerieVaccine

ThemaImmunology

ThemaPandemics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(907)
Mit Volltextzugriff
(907)

Publikationsform

Artikel
(907)

Sprache

Englisch
(907)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(905)
Medicine, Research & Experimental
(905)
Research & Experimental Medicine
(905)
Science & Technology
(905)
Vaccines
(847)
Covid-19 Vaccines
(820)
Covid-19
(736)
Humans
(717)
Coronaviruses
(591)
Immunization
(550)
Public Health
(471)
Vaccination
(443)
Covid-19 - Prevention & Control
(431)
Severe Acute Respiratory Syndrome Coronavirus 2
(411)
Sars-Cov-2
(358)
Viral Diseases
(259)
Disease Transmission
(241)
Infections
(235)

13 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(907)
IngentaConnect
(907)
Elsevier ScienceDirect Journals Complete
(907)
MEDLINE
(745)
Wiley-Blackwell Journals
(0)

Neu hinzugefügt

... seit 90 Tagen
(35)

Menü

Weitere Dienste

Einstellungen

The demand for a COVID-19 vaccine in Ecuador

New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates

Intradermal fractional dose vaccination as a method to vaccinate individuals with suspected allergy to mRNA COVID-19 vaccines

COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies

Editorial: ML-driven vaccine against COVID-19: Developmental challenges and foresight

Case-cohort design as an efficient approach to evaluating COVID-19 vaccine effectiveness, waning, heterologous immune effect and optimal dosing interval

Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study

Intranasal immunization with the bivalent SARS-CoV-2 vaccine effectively protects mice from nasal infection and completely inhibits disease development

Insights from an observational translational research program during the COVID-19 pandemic: Four years of experience

Leveraging a clinical emergency department dataset to estimate two-dose COVID-19 vaccine effectiveness and duration of protection in Canada

Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial

Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient

mRNA-based COVID-19 vaccination of lung transplant recipients with prior SARS-CoV-2 infection induces durable SARS-CoV-2-specific antibodies and T cells

Longitudinal multiomic profiling and corticosteroid modulation of the immediate innate immune response to an adenovirus-vector vaccine

Nonclinical safety assessment and immunogenicity of rVSVInd(GML)-mspSGtc vaccine for SARS-CoV-2 in rabbits

Mammalian cell expressed recombinant trimeric spike protein is a potent vaccine antigen and confers near-complete protection against SARS-CoV-2 infection in Hamster

Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell lines

Safe plant Hsp90 adjuvants elicit an effective immune response against SARS-CoV2-derived RBD antigen

Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group

Non-specific effects of the inactivated influenza vaccine. A test-negative study: The inactivated influenza vaccine and SARS-CoV-2 infections

Immunity of Canadians and risk of epidemics workshop – Conference report

Seroprevalence of B. pertussis infection and the changes of specific antibody levels in health care workers during the first two years of COVID-19 in Wuhu, China

Importance of COVID-19 vaccine efficacy in older age groups

A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccine

Avidity assay to test functionality of anti-SARS-Cov-2 antibodies

Aktive Filter

Suchergebnisse filtern